Annual Shareholders Equity
$69.12 M
-$57.62 M-45.47%
31 December 2023
Summary:
Talis Biomedical annual stockholders equity is currently $69.12 million, with the most recent change of -$57.62 million (-45.47%) on 31 December 2023. During the last 3 years, it has fallen by -$164.86 million (-70.46%). TLIS annual shareholders equity is now -70.46% below its all-time high of $233.98 million, reached on 31 December 2021.TLIS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$48.63 M
-$8.06 M-14.22%
30 June 2024
Summary:
Talis Biomedical quarterly stockholders equity is currently $48.63 million, with the most recent change of -$8.06 million (-14.22%) on 30 June 2024. Over the past year, it has dropped by -$20.49 million (-29.65%). TLIS quarterly shareholders equity is now -86.35% below its all-time high of $356.33 million, reached on 31 March 2021.TLIS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TLIS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -29.6% |
| 3 y3 years | -70.5% | -79.2% |
| 5 y5 years | +426.9% | +330.0% |
TLIS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -70.5% | +163.7% | -81.2% | at low |
| 5 y | 5 years | -70.5% | +163.7% | -86.3% | +144.8% |
| alltime | all time | -70.5% | +163.7% | -86.3% | +144.8% |
Talis Biomedical Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $48.63 M(-14.2%) |
| Mar 2024 | - | $56.68 M(-18.0%) |
| Dec 2023 | $69.12 M(-45.5%) | $69.12 M(-15.3%) |
| Sept 2023 | - | $81.56 M(-15.2%) |
| June 2023 | - | $96.17 M(-12.7%) |
| Mar 2023 | - | $110.12 M(-13.1%) |
| Dec 2022 | $126.74 M | $126.74 M(-16.8%) |
| Sept 2022 | - | $152.39 M(-13.9%) |
| June 2022 | - | $177.02 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $202.78 M(-13.3%) |
| Dec 2021 | $233.98 M(-315.5%) | $233.98 M(-9.6%) |
| Sept 2021 | - | $258.79 M(-11.9%) |
| June 2021 | - | $293.73 M(-17.6%) |
| Mar 2021 | - | $356.33 M(-428.2%) |
| Dec 2020 | -$108.57 M(+413.6%) | -$108.57 M(+64.6%) |
| Sept 2020 | - | -$65.94 M(+211.9%) |
| Dec 2019 | -$21.14 M(-59.3%) | -$21.14 M |
| Dec 2018 | -$52.00 M | - |
FAQ
- What is Talis Biomedical annual stockholders equity?
- What is the all time high annual shareholders equity for Talis Biomedical?
- What is Talis Biomedical quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Talis Biomedical?
- What is Talis Biomedical quarterly shareholders equity year-on-year change?
What is Talis Biomedical annual stockholders equity?
The current annual shareholders equity of TLIS is $69.12 M
What is the all time high annual shareholders equity for Talis Biomedical?
Talis Biomedical all-time high annual stockholders equity is $233.98 M
What is Talis Biomedical quarterly stockholders equity?
The current quarterly shareholders equity of TLIS is $48.63 M
What is the all time high quarterly shareholders equity for Talis Biomedical?
Talis Biomedical all-time high quarterly stockholders equity is $356.33 M
What is Talis Biomedical quarterly shareholders equity year-on-year change?
Over the past year, TLIS quarterly stockholders equity has changed by -$20.49 M (-29.65%)